(Q42225318)

19 October 2017

title

Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea (English)

1 reference

19 October 2017

1 reference

8

Angela Kelly-Hanku

0 references

Peter M Siba

9

object named as

Peter M Siba

1 reference

19 October 2017

Janet Gare

1

1 reference

19 October 2017

Claire E Ryan

2

1 reference

19 October 2017

Matthew David

3

1 reference

19 October 2017

Diana Timbi

4

1 reference

19 October 2017

Petronia Kaima

5

1 reference

19 October 2017

Zure Kombati

6

1 reference

19 October 2017

Ulato Imara

7

1 reference

19 October 2017

Angela Kelly-Hanku

8

1 reference

19 October 2017

Suzanne M Crowe

10

1 reference

19 October 2017

Anna C Hearps

11

1 reference

19 October 2017

language of work or name

English

0 references

publication date

9 April 2014

1 reference

Journal of Antimicrobial Chemotherapy

19 October 2017

published in

1 reference

19 October 2017

volume

69

1 reference

19 October 2017

issue

8

1 reference

19 October 2017

page(s)

2183-2186

1 reference

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Stability of dried blood spots for HIV-1 drug resistance analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

The HIVdb system for HIV-1 genotypic resistance interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

Transmitted HIV drug resistance in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU089

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU089

1 reference

19 October 2017

1 reference